USSTOCK.TODAY
Market Closed
Log in Sign up

US FDA Approves Alvotech's New Manufacturing Process for Simlandi

Investing.com · ·by G4L

ALVO
ALVO Alvotech
$4.19 -10.28%
View chart & analysis →
  1. 1Alvotech shares rose more than 6% during Tuesday pre-market trading.
  2. 2The US Food and Drug Administration has approved a new manufacturing process for Simlandi.
  3. 3Alvotech's production of drug ingredients per batch will more than double without changes to upstream manufacturing scale.

So what's the key point?

The US Food and Drug Administration has authorized a new way for Alvotech to make its medicine. The stock price rose more than 6% because the company can now produce more than twice as much medicine per batch.

Source Investing.com · View original ↗

Related 3-line summaries

Alvotech expects product sales recovery and record Q4 results The Motley Fool +1 · yesterdayAlvotech SA shares jump 13.5% on US FDA supplemental approval for AVT02 manufacturing facility Investing.com +1 · Oct 6UK labor market data released amid pound rise and dollar correction Investing.com · Oct 20
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news